Analyst Recommendations
1.16 0.02(1.31%)05/17/2024
Akebia Therapeutics Inc. (AKBA)
Akebia Therapeutics Inc. (AKBA)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 2 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades